Martínez-Martínez Honorio J, Ferreiro Lucía, Landín Elisa, Fanego Ainoa, Soto-Feijóo Roi, Carreiras-Cuiña María, Rodríguez-Núñez Nuria, Toubes María E, Valdés Luis
Pulmonology Department, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Health Research Institute of Santiago de Compostela, Santiago de Compostela, Spain.
J Thorac Dis. 2025 Jul 31;17(7):5320-5329. doi: 10.21037/jtd-2024-2192. Epub 2025 Jul 22.
Immunoglobulin G4-related disease (IgG4-RD) is a fibroinflammatory condition that rarely affects the pleura, with pleural effusion (PE) reported in only 4% of cases. The characteristics of PE in patients with IgG4-RD are unknown. The objectives of this systematic review were to document the histological and biochemical characteristics of PF and pleural tissue, assess its clinical course, and determine the most effective treatments for the management of PE.
A PRISMA literature search was conducted for published articles describing the characteristics of PE in IgG4-RD and discussing the approach to PE in this setting.
A total of 46 articles [55 patients and 57 pleural fluid (PF) samples] were included. Median age was 66 years (range, 28-86 years), with a male/female ratio of 2.9:1. PE was predominantly right-sided or bilateral (81.3%) and usually occupied <2/3 of the hemithorax (78.9%). PF generally had a serous appearance (84.2%) and was an exudate in 94.6% of cases with predominance (≥50%) of mononucleated cells in 96% (24/25). A predominance of eosinophils (≥10%) was observed in 40% (4/10 cases). As many as 66.7% of patients presented values of adenosine deaminase (ADA) ≥35 U/L (18/27), pH values remained within normal range 7.35-7.45 (15.4%) in only two patients. Three patients had glucose values <60 mg/dL (12.5%) and the PF of two patients was a chylothorax. Pleural biopsy was consistent with diagnosis in 95.6% of cases (43/45). In total, 92.7% of patients (51/55) received treatment with corticosteroids, and 9 (17.6%) received immunosuppressants. Of the four cases left untreated, 2 underwent chest drainage. Clinical course was benign in 97.7% of patients (43/44; a patient died of unknown causes).
Patients with IgG4-RD and PE are usually men over 50 years of age with small/moderate, right-sided or bilateral PE. PF is most commonly a lymphocytic exudate with elevated ADA values. Pleural biopsy can help establish diagnosis. Treatment with corticosteroids, combined or not with immunosuppressants, was usually effective.
免疫球蛋白G4相关性疾病(IgG4-RD)是一种纤维炎症性疾病,很少累及胸膜,仅有4%的病例报告有胸腔积液(PE)。IgG4-RD患者胸腔积液的特征尚不清楚。本系统评价的目的是记录胸腔积液和胸膜组织的组织学和生化特征,评估其临床病程,并确定治疗胸腔积液最有效的方法。
采用PRISMA文献检索法,检索已发表的描述IgG4-RD患者胸腔积液特征并讨论该情况下胸腔积液治疗方法的文章。
共纳入46篇文章[55例患者和57份胸腔积液(PF)样本]。中位年龄为66岁(范围28-86岁),男女比例为2.9:1。胸腔积液主要位于右侧或双侧(81.3%),通常占据不到半侧胸腔的2/3(78.9%)。胸腔积液通常呈浆液性外观(84.2%),94.6%的病例为渗出液,96%(24/25)的病例以单核细胞为主(≥50%)。40%(4/10例)观察到嗜酸性粒细胞占优势(≥10%)。多达66.7%的患者腺苷脱氨酶(ADA)值≥35 U/L(18/27),仅2例患者的pH值保持在正常范围7.35-7.45(15.4%)。3例患者血糖值<60 mg/dL(12.5%),2例患者的胸腔积液为乳糜胸。95.6%的病例(43/45)胸膜活检与诊断一致。总共92.7%的患者(51/55)接受了糖皮质激素治疗,9例(17.6%)接受了免疫抑制剂治疗。在4例未接受治疗的病例中,2例进行了胸腔引流。97.7%的患者(43/44;1例患者死于不明原因)临床病程为良性。
IgG4-RD合并胸腔积液的患者通常为50岁以上男性,胸腔积液为少量/中等量,位于右侧或双侧。胸腔积液最常见的是淋巴细胞渗出液,ADA值升高。胸膜活检有助于确诊。糖皮质激素联合或不联合免疫抑制剂治疗通常有效。